RWE – From real world data to real world evidence
Real world data (RWD) refers to health data that can be used, for example, for demonstrating the value of a certain treatment or technology for patients, healthcare service providers or the society (RWE). Due to a comprehensive healthcare, data in digital format, a personal ID and a progressive research legislation, Finland is a true model country for Real World Evidence studies.
Medaffcon has conducted RWE studies from 2013 onwards; we thus hold a wide-ranging experience in the analytics and utilisation of real world data. We are intensively involved in supporting the development of biobanks, and our cooperation networks with biobanks and other register holders are strong.
In Medaffcon’s RWE studies, we have gathered new knowledge in different therapeutic areas, including:
- Disease burden of different patient groups
- Use of healthcare resources
- Diagnostics of rare diseases
- Treatment lines
- Characteristics of patient subgroups
- Regional differences and treatment practices
Real World Evidence tailored to your needs!
Our process for conducting studies is clear and has been proven effective. Our scientific experts and bioinformaticians ensure that the right research methods and data sources are utilised to answer your question.
The entire process is conducted with solid RWE knowledge and expertise.